LeMaitre Vascular (LMAT) – Analysts’ Recent Ratings Updates

LeMaitre Vascular (NASDAQ: LMAT) has recently received a number of price target changes and ratings updates:

• 8/14/2026 – LeMaitre Vascular was downgraded by Weiss Ratings from “buy (b-)” to “hold (c+)”.
• 8/5/2026 – LeMaitre Vascular had its price target lowered by Wells Fargo & Company from $104.00 to $94.00. They now have an “equal weight” rating on the stock.
• 8/5/2026 – LeMaitre Vascular was downgraded by Barrington Research from “outperform” to “market perform”.
• 8/1/2026 – LeMaitre Vascular was downgraded by Wall Street Zen from “buy” to “hold”.
• 7/21/2026 – LeMaitre Vascular had its “market outperform” rating reaffirmed by Citigroup Inc..
• 7/6/2026 – LeMaitre Vascular was downgraded by Zacks Research from “strong-buy” to “hold”.
• 7/4/2026 – LeMaitre Vascular was upgraded by Wall Street Zen from “hold” to “buy”.
• 6/30/2026 – LeMaitre Vascular was downgraded by Weiss Ratings from “buy (b)” to “buy (b-)”.
• 6/20/2026 – LeMaitre Vascular was downgraded by Wall Street Zen from “buy” to “hold”.

LeMaitre Vascular Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Thursday, August 20th will be paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date of this dividend is Thursday, August 20th. LeMaitre Vascular’s payout ratio is 35.09%.

LeMaitre Vascular, Inc is a specialty medical device company focused on the development, manufacture and marketing of products for the treatment of peripheral vascular disease. Headquartered in Burlington, Massachusetts, the company’s offerings include a broad portfolio of vascular surgical instruments, grafts, patches, catheters and embolic protection devices. LeMaitre’s product lines address key areas such as arterial reconstruction, endovascular repair and vascular access, serving the needs of cardiovascular surgeons and interventional specialists.

Founded in 1983 by George D.